Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akiba

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Japanese Journal of Clinical Oncology|July 10, 1998
Diagnosis and treatment of malignant lymphoma of the parotid glandN Hirokawa, M Hareyama, H Akiba, et al.
The Journal of Biological Chemistry|May 28, 1998
CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinaseH Akiba, H Nakano, S Nishinaka, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Radiotherapy for Kimura's disease: the optimum dosageM Hareyama, A Oouchi, H Nagakura, et al.
Annals of Surgery|October 31, 2001
Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activationK Seino, Y Setoguchi, T Ogino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activationH Nakano, S Sakon, H Koseki, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 7, 2004
Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survivalH R Cho, B Kwon, H Yagita, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Japanese Journal of Clinical Oncology|July 10, 1998
Diagnosis and treatment of malignant lymphoma of the parotid glandN Hirokawa, M Hareyama, H Akiba, et al.
The Journal of Biological Chemistry|May 28, 1998
CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinaseH Akiba, H Nakano, S Nishinaka, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Radiotherapy for Kimura's disease: the optimum dosageM Hareyama, A Oouchi, H Nagakura, et al.
Annals of Surgery|October 31, 2001
Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activationK Seino, Y Setoguchi, T Ogino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activationH Nakano, S Sakon, H Koseki, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 7, 2004
Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survivalH R Cho, B Kwon, H Yagita, et al.
Pageof 10